Optimizing individual treatment outcomes in men with lower urinary tract symptoms using storage subscale score/total International Prostate Symptom Score (IPSS) as a new IPSS ratio

To evaluate the effects of the storage/total International Prostate Symptom Score (s/T) ratio on the selection and success of medical therapy in men with lower urinary tract symptoms (LUTS). Materials and methods: A total of 54 men (>45 years of age) with moderate or severe LUTS were divided into 2 groups according to the s/T ratio: Group 1 at 0.43. Tamsulosin (0.4 mg to Group 1) and tolterodine ER (4 mg to Group 2) were administered. Patients were evaluated during the 1st and 3rd months of follow-up treatment. Results: Thirty-seven (68.5%) and 17 (31.5%) patients were in Groups 1 and 2, respectively. The mean s/T ratios in Groups 1 and 2 increased to 0.38 ± 0.19 from 0.33 ± 0.08 (P = 0.03) and decreased to 0.54 ± 0.18 from 0.59 ± 0.1 (P = 0.17) during the 3rd month of follow-up, respectively. The treatment success rates of Groups 1 and 2 were 88.4% and 75.7%, respectively. Nine unsuccessful cases were treated with combination therapy and the treatment success was 86.6% at follow-up. Conclusion: The s/T ratio is effective to determine symptom dominance in men with LUTS and can guide medical treatment selection through better identification of symptoms.

Optimizing individual treatment outcomes in men with lower urinary tract symptoms using storage subscale score/total International Prostate Symptom Score (IPSS) as a new IPSS ratio

To evaluate the effects of the storage/total International Prostate Symptom Score (s/T) ratio on the selection and success of medical therapy in men with lower urinary tract symptoms (LUTS). Materials and methods: A total of 54 men (>45 years of age) with moderate or severe LUTS were divided into 2 groups according to the s/T ratio: Group 1 at 0.43. Tamsulosin (0.4 mg to Group 1) and tolterodine ER (4 mg to Group 2) were administered. Patients were evaluated during the 1st and 3rd months of follow-up treatment. Results: Thirty-seven (68.5%) and 17 (31.5%) patients were in Groups 1 and 2, respectively. The mean s/T ratios in Groups 1 and 2 increased to 0.38 ± 0.19 from 0.33 ± 0.08 (P = 0.03) and decreased to 0.54 ± 0.18 from 0.59 ± 0.1 (P = 0.17) during the 3rd month of follow-up, respectively. The treatment success rates of Groups 1 and 2 were 88.4% and 75.7%, respectively. Nine unsuccessful cases were treated with combination therapy and the treatment success was 86.6% at follow-up. Conclusion: The s/T ratio is effective to determine symptom dominance in men with LUTS and can guide medical treatment selection through better identification of symptoms.

Kaynakça

Chapple CR, Roehrborn CG. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder. Eur Urol 2006; 49: 651–658.

Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327–336.

Temml C, Heidler S, Ponholzer A, Madersbacher S. Prevalence of the overactive bladder syndrome by applying the International Continence Society definition. Eur Urol 2005; 48: 622–627.

Kaplan SA, Roehrborn CG, Chancellor M, Carlsson M, Bavendam T, Guan Z. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score. BJU Int 2008; 102: 1133–1139.

de Nunzio C, Franco G, Rocchegiani A, Iori F, Leonardo C, Laurenti C. The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction. J Urol 2003; 169: 535–539.

Liao CH, Chung SD, Kuo HC. Diagnostic value of International Prostate Symptom Score voiding-to-storage subscore ratio in male lower urinary tract symptoms. Int J Clin Pract 2011; 65: 552–558.

Liao CH, Lin VC, Chung SD, Kuo HC. Therapeutic effect of alpha-blockers and antimuscarinics in male lower urinary tract symptoms based on the International Prostate Symptom Score subscore ratio. Int J Clin Pract 2012; 66: 139–145.

Lee JY, Kim HW, Lee SJ, Koh JS, Suh HJ, Chancellor MB. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU Int 2004; 94: 817–820.

Roehrborn CG, Siami P, Barkin J, Damiao R, Major-Walker K, Nandy I, Morrill BB, Gagnier RP, Montorsi F; CombAT Study Group. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol 2010; 57: 123–131.

Roehrborn CG. The Agency for Health Care Policy and Research. Clinical guidelines for the diagnosis and treatment of benign prostatic hyperplasia. Urol Clin North Am 1995; 22: 445–453.

Abrams P, Kaplan S, De Koning Gans HJ, Millard R. Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction. J Urol 2006; 175: 999–1004.

Kaplan SA, Walmsley K, Te AE. Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia. J Urol 2005; 174: 2273–2275; discussion 2275–2276.

Kaplan SA, Roehrborn CG, Dmochowski R, Rovner ES, Wang JT, Guan Z. Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia. Urology 2006; 68: 328–332.

Roehrborn CG, Abrams P, Rovner ES, Kaplan SA, Herschorn S, Guan Z. Efficacy and tolerability of tolterodine extended- release in men with overactive bladder and urgency urinary incontinence. BJU Int 2006; 97: 1003–1006.

Roehrborn CG, Kaplan SA, Jones JS, Wang JT, Bavendam T, Guan Z. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size. Eur Urol 2009; 55: 472–479.

Roehrborn CG, Kaplan SA, Kraus SR, Wang JT, Bavendam T, Guan Z. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB. Urology 2008; 72: 1061–1067.

Chapple C, Herschorn S, Abrams P, Sun F, Brodsky M, Guan Z. Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers. Eur Urol 2009; 56: 534-541.

Song K, Choo MS, Lee KS, Han JY, Lee YS, Kim JC, Cho JS. The long-term effect of alfuzosin in patients with lower urinary tract symptoms suggestive of benign prostate hyperplasia: evaluation of voiding and storage function with respect to bladder outlet obstruction grade and contractility. Urology 2011; 77: 1177–1182.

Kaynak Göster

Bibtex @ { tbtkmedical148850, journal = {Turkish Journal of Medical Sciences}, issn = {1300-0144}, eissn = {1303-6165}, address = {}, publisher = {TÜBİTAK}, year = {2014}, volume = {44}, pages = {1124 - 1129}, doi = {10.3906/sag-1209-86}, title = {Optimizing individual treatment outcomes in men with lower urinary tract symptoms using storage subscale score/total International Prostate Symptom Score (IPSS) as a new IPSS ratio}, key = {cite}, author = {Altıntaş, Serkan and Acar, İsmail Cenk and Eskiçorapçı, Saadettin Yılmaz and Zümrütbaş, Ali Ersin} }
APA Altıntaş, S , Acar, İ , Eskiçorapçı, S , Zümrütbaş, A . (2014). Optimizing individual treatment outcomes in men with lower urinary tract symptoms using storage subscale score/total International Prostate Symptom Score (IPSS) as a new IPSS ratio . Turkish Journal of Medical Sciences , 44 (6) , 1124-1129 . DOI: 10.3906/sag-1209-86
MLA Altıntaş, S , Acar, İ , Eskiçorapçı, S , Zümrütbaş, A . "Optimizing individual treatment outcomes in men with lower urinary tract symptoms using storage subscale score/total International Prostate Symptom Score (IPSS) as a new IPSS ratio" . Turkish Journal of Medical Sciences 44 (2014 ): 1124-1129 <
Chicago Altıntaş, S , Acar, İ , Eskiçorapçı, S , Zümrütbaş, A . "Optimizing individual treatment outcomes in men with lower urinary tract symptoms using storage subscale score/total International Prostate Symptom Score (IPSS) as a new IPSS ratio". Turkish Journal of Medical Sciences 44 (2014 ): 1124-1129
RIS TY - JOUR T1 - Optimizing individual treatment outcomes in men with lower urinary tract symptoms using storage subscale score/total International Prostate Symptom Score (IPSS) as a new IPSS ratio AU - Serkan Altıntaş , İsmail Cenk Acar , Saadettin Yılmaz Eskiçorapçı , Ali Ersin Zümrütbaş Y1 - 2014 PY - 2014 N1 - doi: 10.3906/sag-1209-86 DO - 10.3906/sag-1209-86 T2 - Turkish Journal of Medical Sciences JF - Journal JO - JOR SP - 1124 EP - 1129 VL - 44 IS - 6 SN - 1300-0144-1303-6165 M3 - doi: 10.3906/sag-1209-86 UR - Y2 - 2021 ER -
EndNote %0 Turkish Journal of Medical Sciences Optimizing individual treatment outcomes in men with lower urinary tract symptoms using storage subscale score/total International Prostate Symptom Score (IPSS) as a new IPSS ratio %A Serkan Altıntaş , İsmail Cenk Acar , Saadettin Yılmaz Eskiçorapçı , Ali Ersin Zümrütbaş %T Optimizing individual treatment outcomes in men with lower urinary tract symptoms using storage subscale score/total International Prostate Symptom Score (IPSS) as a new IPSS ratio %D 2014 %J Turkish Journal of Medical Sciences %P 1300-0144-1303-6165 %V 44 %N 6 %R doi: 10.3906/sag-1209-86 %U 10.3906/sag-1209-86
ISNAD Altıntaş, Serkan , Acar, İsmail Cenk , Eskiçorapçı, Saadettin Yılmaz , Zümrütbaş, Ali Ersin . "Optimizing individual treatment outcomes in men with lower urinary tract symptoms using storage subscale score/total International Prostate Symptom Score (IPSS) as a new IPSS ratio". Turkish Journal of Medical Sciences 44 / 6 (Haziran 2014): 1124-1129 .
AMA Altıntaş S , Acar İ , Eskiçorapçı S , Zümrütbaş A . Optimizing individual treatment outcomes in men with lower urinary tract symptoms using storage subscale score/total International Prostate Symptom Score (IPSS) as a new IPSS ratio. Turkish Journal of Medical Sciences. 2014; 44(6): 1124-1129.
Vancouver Altıntaş S , Acar İ , Eskiçorapçı S , Zümrütbaş A . Optimizing individual treatment outcomes in men with lower urinary tract symptoms using storage subscale score/total International Prostate Symptom Score (IPSS) as a new IPSS ratio. Turkish Journal of Medical Sciences. 2014; 44(6): 1124-1129.
IEEE S. Altıntaş , İ. Acar , S. Eskiçorapçı ve A. Zümrütbaş , "Optimizing individual treatment outcomes in men with lower urinary tract symptoms using storage subscale score/total International Prostate Symptom Score (IPSS) as a new IPSS ratio", Turkish Journal of Medical Sciences, c. 44, sayı. 6, ss. 1124-1129, Haz. 2014, doi:10.3906/sag-1209-86
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK

24.7b 23.8b

Sayıdaki Diğer Makaleler

Comparison of estrogen and betamethasone in the topical treatment of labial adhesions in prepubertal girls

Nazile ERTÜRK

Evaluation of scleral-fixated intraocular lens position anomalies by anterior segment optical coherence tomography

Nihat POLAT, Kemalettin Kazım DEVRANOĞLU, Mehmet Akif ÖZDAMAR, Ceyhun ARICI

The comparison of pandemic H1N1 IgG levels between H1N1 influenza-vaccinated healthcare workers and unvaccinated healthcare workers

Aydın ÇİFCİ, Özlem EROL, Salih CESUR, Nurkan AKSOY, Üçler KISA

Serum fetuin-A levels in postmenopausal women with osteoporosis

Esin ÖZKAN, Hüseyin ÖZKAN, Serkan BİLGİÇ, Ersin ODABAŞI, Nuray CAN, Emin Özgür AKGÜL, İbrahim YANMIŞ, Yüksel YURTTAŞ, Mustafa KÜRKLÜ, Mustafa BAŞBOZKURT, Mehmet Kemal ERBİL

Evaluation report of pediatric intensive care units in Turkey

Benan BAYRAKCI, Selman KESİCİ, Tanıl KENDİRLİ, Gökhan KALKAN, Aydın SARI

Investigation of linezolid resistance in Staphylococcus epidermidis: first reported linezolid resistant coagulase negative staphylococcus in Turkey

Barış YALÇIN, Mehmet Burak SELEK, Bayhan BEKTÖRE, Tuğrul HOŞBUL, Mustafa ÖZYURT

Endobronchial ultrasound-guided transbronchial needle biopsy for the diagnosis of mediastinal lymphadenopathy in patients with extrathoracic malignancies

Ayşegül ŞENTÜRK, Hatice KILIÇ, Habibe HEZER, Funda KARADUMAN YALÇIN, Hatice Canan HASANOĞLU

Effect of nodule size on the reliability of fine-needle aspiration biopsy in thyroid nodules

Ali Erkan UÇAR, Seyit Muhsin SARIKAYA, Ömer PARLAK, Abdussamed YALÇIN

Investigation of serum macrophage migration inhibitor factor and monocyte chemotactic protein-1 levels in irritable bowel syndrome

Feti TÜLÜBAŞ, Mustafa ORAN, Rafet METE, Filiz TURAN, Ahsen YILMAZ, Zeynep Deniz YILDIZ, Ahmet GÜREL

Detection the frequency of PER-1 type extended-spectrum ß-lactamase-producing Acinetobacter baumannii clinical isolates in Turkey: a multicenter study

Detection Of The Frequency Of Per- Type STUDY